Home NDC 50090-5756-2 Cyclobenzaprine hydrochloride
Product NDC 50090-5756
Requested package NDC 50090-5756-2
11-digit product format 500905756
Labeler code 50090
Product ID 50090-5756_1882fcff-f03c-4c72-9202-397e9643c330
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cyclobenzaprine hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler A-S Medication Solutions
Application ANDA213324
Marketing category ANDA
Marketing start 2020-07-06
Substance CYCLOBENZAPRINE HYDROCHLORIDE
Active strength 5 mg/1
Pharmacologic classes Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 c2088c7a36db…2026-09-14 22:38:34 2026-08 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Cyclobenzaprine hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CYCLOBENZAPRINE HYDROCHLORIDE 5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 0VE05JYS2P Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 828320 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 50090-5756-0 2023-02-06 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-0 2023-02-06 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-1 2023-02-06 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-1 2023-02-06 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-2 2023-02-06 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-2 2023-02-06 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-3 2023-02-06 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-3 2023-02-06 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-0 2023-01-30 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-0 2023-01-30 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-1 2023-01-30 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-1 2023-01-30 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-2 2023-01-30 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-2 2023-01-30 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-3 2023-01-30 Cyclobenzaprine hydrochloride Tablets, USP 50090-5756-3 2023-01-30 Cyclobenzaprine hydrochloride Tablets, USP
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-5756-0 Cyclobenzaprine hydrochloride 30 in 1 BOTTLE TABLET, FILM COATED 30 11 50090-5756-1 Cyclobenzaprine hydrochloride 20 in 1 BOTTLE TABLET, FILM COATED 20 11 50090-5756-2 Cyclobenzaprine hydrochloride 90 in 1 BOTTLE TABLET, FILM COATED 90 11 50090-5756-3 Cyclobenzaprine hydrochloride 24 in 1 BOTTLE TABLET, FILM COATED 24 11 50090-5756-4 Cyclobenzaprine hydrochloride 10 in 1 BOTTLE TABLET, FILM COATED 10 11
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-5756 CYCLOBENZAPRINE HYDROCHLORIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] 11 Current NDC, Legacy NDC, 5 package rows 20240530_f2286776-a7de-42dc-b745-d250e741eeb6.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 25 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Cyclobenzaprine hydrochloride CYCLOBENZAPRINE HYDROCHLORIDE NuCare Pharmaceuticals,Inc. c68d17e2-2311-8e17-e053-2995a90a565b 2024-03-11 Warnings, Adverse reactions Exact identifier application applno (ANDA): 213324 application number: ANDA213324 Cyclobenzaprine hydrochloride CYCLOBENZAPRINE HYDROCHLORIDE Bryant Ranch Prepack 4a2d3cae-5c64-4986-9707-cc213b70b7ad 2023-10-19 Warnings, Adverse reactions Exact identifier application applno (ANDA): 213324 application number: ANDA213324 Cyclobenzaprine hydrochloride CYCLOBENZAPRINE HYDROCHLORIDE Bryant Ranch Prepack 6ebaccfc-f57c-4547-ade0-6a6e204f5ea0 2023-03-27 Warnings, Adverse reactions Exact identifier application applno (ANDA): 213324 application number: ANDA213324 Cyclobenzaprine hydrochloride CYCLOBENZAPRINE HYDROCHLORIDE Unichem Pharmaceuticals (USA), Inc. 1adcdd8a-30f9-4a7b-853c-948a5589acab 2023-01-03 Warnings, Adverse reactions Exact identifier application applno (ANDA): 213324 application number: ANDA213324 Cyclobenzaprine hydrochloride CYCLOBENZAPRINE HYDROCHLORIDE Asclemed USA, Inc. 59945ea1-8136-4014-acd9-cdfe6e11e8da 2022-07-19 Warnings, Adverse reactions Exact identifier application applno (ANDA): 213324 application number: ANDA213324
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 50090-5756-2 50090575602 90 TABLET, FILM COATED in 1 BOTTLE (50090-5756-2) 2021-10-01 0000-00-00 No No Current